Intelligence Ventures invested $25K in Evidexa as part of IV Accelerator Cohort I. Evidexa simulates real patient behavior to help healthcare teams test formulary decisions and market-access strategies before launch.
Evidexa builds synthetic audiences from interviews with real people to simulate human behavior in healthcare decision-making
Evidexa builds synthetic audiences from interviews with real people to simulate human behavior in healthcare decision-making.